protein translation

How is Protein Translation Dysregulated in Cancer?

In cancer, several mechanisms can lead to the dysregulation of protein translation. These include:
Mutations in genes encoding translation factors
Overexpression of oncogenic pathways like the mTOR pathway
Altered expression of microRNAs that regulate translation
Changes in the availability of ribosomal proteins
These alterations can result in the selective translation of oncogenes and other proteins that promote cancer progression.

Frequently asked queries:

How Does Protein Translation Work?
How is Protein Translation Dysregulated in Cancer?
Which Cancer Types are Most Affected by Translation Dysregulation?
Can Protein Translation be Targeted for Cancer Therapy?
What are the Challenges in Targeting Protein Translation?
How is Diesel Exhaust Linked to Cancer?
What Are the Limitations of PDB Data in Cancer Research?
How is Cancer Profiling Conducted?
How Do Different Types of Cancer Treatments Compare in Cost?
Why is Review and Evaluation Important?
What Types of Cancer Are Associated with Alcohol Consumption?
What Are the Future Directions in MMP Research?
What is Epigenomics?
What is the Prognosis for Patients with Multicentric Castleman's Disease?
How Do Purine Analogues Work?
How Do Biotechnological Methods Improve Cancer Diagnostics?
What is Plug-in Support in Cancer?
How Can Donors Use Charity Navigator to Choose a Cancer Charity?
What Role Does Interim Data Play in Adaptive Trials?
Why is Real-Time Access Important?
Top Searches
Brain Tumor Breast cancer cancer Cancer Genomics Chemotherapy hepatocellular carcinoma Lung Cancer Nanotechnology Non-Hodgkin’s Lymphoma Radiation-Induced Malignancies
Follow Us

Partnered Content Networks

Relevant Topics